The Nomination Committee of Probi has been appointed

AP4 is represented by Jannis Kitsakis, Portfolio Manager.

The Nomination Committee of Probi has now been appointed in accordance with the AGM resolutions.

AP4 is represented by Jannis Kitsakis, Portfolio Manager.

The other members in the committee are:

  • Heinz-Jürgen Bertram, Symrise
  • Marianne Flink, Swedbank Robur Fonder
  • Bengt Jepsson, Lunds universitet


About Probi
Probi AB is a Swedish publicly traded bioengineering company. The vision of Probi is to help people live healthier lives by delivering effective and well-documented probiotics, with proven health benefits based on scientific research. Founded by scientists in Sweden in 1991, Probi is a multinational company with four sites, active in more than 40 markets around the world and holding over 400 patents worldwide. In 2017, Probi had net sales of MSEK 612. 


Jannis Kitsakis

Jannis Kitsakis is Portfolio manager at AP4 and has now been appointed as member of Probi's nomination committee.